The global head and neck cancer diagnostic market is expected to grow at an impressive CAGR in the forecast period, 2023-2027. The increasing geriatric population who are more prone to numerous chronic diseases such as cancer is driving the growth of the global head and neck cancer diagnostic market.

Inflating disposable income leads to increased healthcare expenditure by the people. Furthermore, the escalating demand for diagnostic imaging, advancing treatment modes, and the incorporation of novel technologies in diagnostics equipment by the market players are expected to stimulate market growth. Also, the increased adoption of sedentary lifestyles and modifications in dietary habits is giving rise to several incidences among consumers, which further contributes to the global head and neck cancer diagnostics market growth. The growing need for targeted therapies and the awareness among the people regarding the availability and effectiveness of several oncological treatment procedures are expected to influence the global head and neck cancer diagnostic market growth in the forecast period.

Increasing Incidences of Cancer Propels the Market Growth

Cancer refers to the uncontrolled and abnormal growth of cells that form a mass known as a tumour that can be cancerous or benign. The adoption of sedentary lifestyles, especially among the working population, leads to various chronic illnesses, including cancer. The growing old age population who are more prone to any chronic diseases as their immune system gets weak further supports the growth of the global head and neck cancer diagnostics market. As per a study by the National Center for Biotechnology Information, head and neck cancer is considered the sixth-most common cancer globally. Regular consumption of tobacco and excessive alcohol consumption also increases the risk of head and neck cancer in consumers.

Rise In Demand for Diagnostic Imaging Equipment Fuels the Market Growth

Diagnostic imaging refers to the technique and procedure of creating visual representations of the interior of a body for medical intervention, visual representation of the function of some organs or tissues, and clinical analysis of any organ. Head and neck cancer refers to the group of cancers that generally begins in the squamous cells that line the mouth, nose, neck, and throat. To detect the accurate location of these kinds of cancer and determine if it has spread, head MRI, CT of the sinuses, head CT, clinical analysis and panoramic dental x-ray, dental cone beam CT, PET/CT, or chest imaging are few of the common diagnostic procedures which are performed upon the patients.

Elevating Need for Effective Targeted Treatment Boosts the Market Growth

Treatment for head and neck cancer is a challenging task for many oncologists. Treatment availability and choice depend upon the location of the cancer and vary from patient to patient. Due to the facial structure’s complexity, the surgical treatments for head and neck cancers become complex, with surgery being the preferred mode of treatment mode among healthcare professionals. Onco-surgeon prefers surgical therapy in combination with radiation therapy for head and neck cancer treatment. For better results after surgery, accurate diagnosis plays a significant role in analyzing the cancer severity. The introduction of targeted molecular therapy, including gene therapy, antibody-drug conjugates, and monoclonal antibodies, offers a potential avenue for the global head and neck cancer diagnostics market.



Click here to download the sample

Market Segmentation

The global head and neck cancer diagnostics market is segmented into type, end user, regional distribution, and competitive landscape. Based on the type, the market is divided into diagnostic imaging, biopsy, endoscopy, and dental diagnostics. Diagnostic imaging is further divided into PET/CT, MRI, X-Ray, and others and biopsy is divided into incisional biopsy, fine needle aspiration biopsy, and HPV testing. Similarly, endoscopy is divided into pharyngoscopy, laryngoscopy, panendoscopy and dental diagnostics is divided into brush biopsy, fluorescence visualization, acetic acid rinse method, toluidine blue dye-based met. Based on the end user, the market is divided into hospitals, specialty clinics, ambulatory surgical centers, and others. The market analysis also studies the regional segmentation, divided among North American region, Asia-Pacific region, European region, South American region, and Middle East & African region.

Market Players

Addent Inc, GE Healthcare, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon Medical system Corporation, Carestream Healthcare Inc., Neusoft Medical Systems Co., Ltd., Varian Medical Systems, Inc. are the key market players leading the growth of the global head and neck cancer diagnostics market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Type

·         End-User

Regional scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Singapore; Malaysia; Germany; United Kingdom; France; Italy; Spain; Poland; Denmark; Brazil; Argentina; Colombia; Poland; Denmark; Saudi Arabia; South Africa; UAE; Iraq; Turkey

Key companies profiled

Addent Inc, GE Healthcare, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon Medical system Corporation, Carestream Healthcare Inc., Neusoft Medical Systems Co., Ltd., Varian Medical Systems, Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global head and neck cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Head and Neck Cancer Diagnostics Market, By Type:
    • Diagnostic Imaging
      • PET/CT
      • MRI
      • X-Ray
      • Others
    • Biopsy
      • Incisional Biopsy
      • Fine Needle Aspiration Biopsy
      • HPV Testing
    • Endoscopy
      • Pharyngoscopy
      • Laryngoscopy
      • Panendoscopy
    • Dental Diagnostics
      • Brush Biopsy
      • Fluorescence Visualization
      • Acetic Acid Rinse Method
      • Toluidine Blue Dye-Based Method
  • Head and Neck Cancer Diagnostics Market, By End-User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others
  • Head and Neck Cancer Diagnostics Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  Saudi Arabia

§  South Africa

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global head and neck cancer diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global head and neck cancer diagnostics market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Type Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Head and Neck Cancer Diagnostics Market

4.    Voice of Customer

5.    Executive Summary

6.    Global Head and Neck Cancer Diagnostics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)

6.2.1.1.         By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)

6.2.1.2.         By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)

6.2.1.3.         By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)

6.2.1.4.         By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)

6.2.2.     By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)

6.2.3.     By Company (2021)

6.2.4.     By Region

6.3.  Product Market Map

7.    North America Head and Neck Cancer Diagnostics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)

7.2.1.1.         By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)

7.2.1.2.         By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)

7.2.1.3.         By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)

7.2.1.4.         By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)

7.2.2.     By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)

7.2.3.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Head and Neck Cancer Diagnostics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By End User

7.3.2.     Mexico Head and Neck Cancer Diagnostics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By End User

7.3.3.     Canada Head and Neck Cancer Diagnostics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By End User

8.    Europe Head and Neck Cancer Diagnostics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)

8.2.1.1.         By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)

8.2.1.2.         By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)

8.2.1.3.         By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)

8.2.1.4.         By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)

8.2.2.     By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)

8.2.3.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Head and Neck Cancer Diagnostics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By End User

8.3.2.     Germany Head and Neck Cancer Diagnostics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By End User

8.3.3.     United Kingdom Head and Neck Cancer Diagnostics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By End User

8.3.4.     Italy Head and Neck Cancer Diagnostics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By End User

8.3.5.     Spain Head and Neck Cancer Diagnostics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By End User

9.    Asia-Pacific Head and Neck Cancer Diagnostics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)

9.2.1.1.         By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)

9.2.1.2.         By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)

9.2.1.3.         By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)

9.2.1.4.         By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)

9.2.2.     By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)

9.2.3.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Head and Neck Cancer Diagnostics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By End User

9.3.2.     India Head and Neck Cancer Diagnostics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By End User

9.3.3.     Japan Head and Neck Cancer Diagnostics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By End User

9.3.4.     South Korea Head and Neck Cancer Diagnostics Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type

9.3.4.2.2.             By End User

9.3.5.     Australia Head and Neck Cancer Diagnostics Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By End User

10.  South America Head and Neck Cancer Diagnostics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)

10.2.1.1.      By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)

10.2.1.2.      By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)

10.2.1.3.      By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)

10.2.1.4.      By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)

10.2.2.  By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)

10.2.3.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Head and Neck Cancer Diagnostics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By End User

10.3.2.  Argentina Head and Neck Cancer Diagnostics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By End User

10.3.3.  Colombia Head and Neck Cancer Diagnostics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By End User

11.  Middle East and Africa Head and Neck Cancer Diagnostics Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)

11.2.1.1.      By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)

11.2.1.2.      By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)

11.2.1.3.      By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)

11.2.1.4.      By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)

11.2.2.  By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)

11.2.3.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Head and Neck Cancer Diagnostics Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By End User

11.3.2.  Saudi Arabia Head and Neck Cancer Diagnostics Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By End User

11.3.3.  UAE Head and Neck Cancer Diagnostics Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Addent Inc

14.2.              GE Healthcare

14.3.              Koninklijke Philips NV

14.4.              Shimadzu Corporation

14.5.              Siemens Healthineers AG

14.6.              Fujifilm Holdings Corporation

14.7.              Canon Medical system Corporation

14.8.              Carestream Healthcare Inc.

14.9.              Neusoft Medical Systems Co., Ltd.

14.10.            Varian Medical Systems, Inc.

15. Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com